1093.HK vs G51: Side-by-Side Comparison
Compare CSPC Pharmaceutical Group Limited (1093.HK) and Genscript Biotech Corporation (G51) side by side: market cap HKD 79.50B vs EUR 2.88B. Financials, growth and model signals on Bullrun.
| Metric | 1093.HK | G51 |
|---|---|---|
| Company | CSPC Pharmaceutical Group Limited | Genscript Biotech Corporation |
| Country / Exchange | Hong Kong | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
| Market cap | HKD 79.50B | EUR 2.88B |
| P/E ratio | 17.9 | — |
| Dividend yield | 4.20% | — |
| Valuation model | — | — |
| Revenue (FY2025) | HKD 26.01B | EUR 959.53M |
| Revenue growth YoY | -10.4% | +61.4% |
| Net income | HKD 3.88B | EUR -532.83M |
| Gross margin | 65.6% | 57.7% |
| Diluted EPS | 0.34 | -0.25 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.